The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt